In MDS, TET2 mutations are found in 20%–25% of patients, but occur at a higher frequency of 30%–60% in chronic myelomonocytic leukemia (CMML) [20,21,22,23]. The gene discussed is TET2; the disease is chronic myelomonocytic leukemia.